INTIMA-MEDIA THICKNESS AND ADHESION MOLECULES SICAM-1 AND SVCAM-1 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL AND DIAGNOSTIC VALUE
Abstract
About the Authors
S. G. KasatkinaRussian Federation
T. N. Panova
Russian Federation
References
1. Algorithms of specialized medical care by sick diabetes. Under the editorship of I.I. Dedova, M.V. Shestakova. 4th prod. M, 2009. Russian (Алгоритмы специализированной медицинской помощи больным сахарным диабетом./Под ред. И.И. Дедова, М.В. Шестаковой. 4 е изд.М., 2009).
2. American Diabetes Association. Standards of medical care in diabetes/diabetes Care. 2009; 32 (Suppl 1): S13 – S16.
3. Diabetic cardiology. Edited by M. Fisher, JJ McMurray.– John Wiley and Sons Ltd.– 2007: 295 p.
4. Balakhonova T.V. Ultrasonic research of arteries at patients with cardiovascular diseases: Dis. Dr.s of medical sciences. M, 2002. Russian (Балахонова Т.В. Ультразвуковое исследование артерий у пациентов с сердечно-сосудистыми заболеваниями: Дисс. д ра мед. наук.М., 2002).
5. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol 2007; 27: 11: 2292–2301.
6. Graninger M., Reiter R., Drucker C. et al. Angiotensin receptor blockade decreases markers of vascular inflammation. J Cardiovasc Pharmacol 2004; 44: 335–339.
7. Guray U., Erbay A.R., Guray Y. Levels of soluble adhesion molecules in various clinical presentations of coronary atherosclerosis. Int J Cardiol 2004; 96: 2: 235–240.
8. Libby P., Ridker P., Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135–1147.
9. Patti G., Chello M., Pasceri V. Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of Myocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. J Am Coll Cardiol 2006; 17; 48: 8: 1560–1566.
10. Postadzhiyan A. S., Tzontcheva A. V. Circulating soluble adhesion molecules 1CAM 1 and VCAM 1 and their association with clinical outcome, troponin T and C reactive protein in patients with acute coronary syndromes. Clin Biochem 2008; 41: 3: 126– 133.
11. Tomiyasu H., Ishikawa K., Yamamoto M. Effect of anticholesterol therapy on soluble 1CAM 1 in chronic stroke patients with hyperlipidemia. Tokai J Exp Clin Med 2005; 30: 1: 63–69.
Review
For citations:
Kasatkina S.G., Panova T.N. INTIMA-MEDIA THICKNESS AND ADHESION MOLECULES SICAM-1 AND SVCAM-1 IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL AND DIAGNOSTIC VALUE. Russian Journal of Cardiology. 2012;(3):47-50. (In Russ.)